Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China · Delayed Price · Currency is CNY 32.03
-0.45 (-1.39%)
Sep 8, 2025, 9:53 AM CST
SHE:300357 Revenue
Zhejiang Wolwo Bio-Pharmaceutical had revenue of 255.76M CNY in the quarter ending June 30, 2025, with 20.07% growth. This brings the company's revenue in the last twelve months to 980.37M, up 10.01% year-over-year. In the year 2024, Zhejiang Wolwo Bio-Pharmaceutical had annual revenue of 925.39M with 9.10% growth.
Revenue (ttm)
980.37M
Revenue Growth
+10.01%
P/S Ratio
17.35
Revenue / Employee
583.90K
Employees
1,679
Market Cap
17.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 925.39M | 77.20M | 9.10% |
| Dec 31, 2023 | 848.19M | -47.83M | -5.34% |
| Jan 1, 2023 | 896.02M | 88.32M | 10.94% |
| Dec 31, 2021 | 807.69M | 171.48M | 26.95% |
| Dec 31, 2020 | 636.21M | -3.14M | -0.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |